Minimal clinically important difference for change in 6‐minute walk test distance of adults with pathology: a systematic review

2016 ◽  
Vol 23 (2) ◽  
pp. 377-381 ◽  
Author(s):  
Richard W. Bohannon ◽  
Rebecca Crouch
Keyword(s):  
Systematic Review ◽  
Minimal Clinically Important Difference ◽  
Walk Test ◽  
Clinically Important Difference ◽  
Test Distance ◽  
6 Minute Walk Test ◽  
Minute Walk

scholarly journals HIV infection is an independent risk factor for decreased 6-minute walk test distance

PLoS ONE ◽  
2019 ◽  
Vol 14 (4) ◽  
pp. e0212975 ◽  
Author(s):  
Tom E. Robertson ◽  
Mehdi Nouraie ◽  
Shulin Qin ◽  
Kristina A. Crothers ◽  
Cathy J. Kessinger ◽  
...  
Keyword(s):  
Risk Factor ◽  
Hiv Infection ◽  
Independent Risk Factor ◽  
Walk Test ◽  
Test Distance ◽  
6 Minute Walk Test ◽  
Minute Walk

scholarly journals Effects of Home‐Based Cardiac Rehabilitation on Time to Enrollment and Functional Status in Patients With Ischemic Heart Disease

2020 ◽  
Vol 9 (19) ◽  
Author(s):  
David W. Schopfer ◽  
Mary A. Whooley ◽  
Kelly Allsup ◽  
Mark Pabst ◽  
Hui Shen ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Cardiac Rehabilitation ◽  
Ischemic Heart ◽  
Walk Test ◽  
Home Based ◽  
Test Distance ◽  
6 Minute Walk Test ◽  
Minute Walk

Background Cardiac rehabilitation is an established performance measure for adults with ischemic heart disease, but patient participation is remarkably low. Home‐based cardiac rehabilitation (HBCR) may be more practical and feasible, but evidence regarding its efficacy is limited. We sought to compare the effects of HBCR versus facility‐based cardiac rehabilitation (FBCR) on functional status in patients with ischemic heart disease. Methods and Results This was a pragmatic trial of 237 selected patients with a recent ischemic heart disease event, who enrolled in HBCR or FBCR between August 2015 and September 2017. The primary outcome was 3‐month change in distance completed on a 6‐minute walk test. Secondary outcomes included rehospitalization as well as patient‐reported physical activity, quality of life, and self‐efficacy. Characteristics of the 116 patients enrolled in FBCR and 121 enrolled in HBCR were similar, except the mean time from index event to enrollment was shorter for HBCR (25 versus 77 days; P <0.001). As compared with patients undergoing FBCR, those in HBCR achieved greater 3‐month gains in 6‐minute walk test distance (+95 versus +41 m; P <0.001). After adjusting for demographics, comorbid conditions, and indication, the mean change in 6‐minute walk test distance remained significantly greater for patients enrolled in HBCR (+101 versus +40 m; P <0.001). HBCR participants reported greater improvements in quality of life and physical activity but less improvement in exercise self‐efficacy. There were no deaths or cardiovascular hospitalizations. Conclusions Patients enrolled in HBCR achieved greater 3‐month functional gains than those enrolled in FBCR. Our data suggest that HBCR may safely derive equivalent benefits in exercise capacity and overall program efficacy in selected patients. Registration URL: https://www.clini​caltr​ials.gov ; Unique identifier: NCT02105246.

Efficacy of Tafamidis by Baseline 6-minute Walk Test Distance in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

2020 ◽  
Vol 26 (10) ◽  
pp. S10
Author(s):  
Mathew S. Maurer ◽  
Eric Adler ◽  
Balarama Gundapaneni ◽  
Marla B. Sultan ◽  
Claudio Rapezzi
Keyword(s):  
Clinical Trial ◽  
Walk Test ◽  
Test Distance ◽  
6 Minute Walk Test ◽  
Minute Walk
Sign in / Sign up

Export Citation Format

Share Document